CATALAYER NEWS
Oncolytics reports 15-month response duration in anal cancer trial
Source: Investing.com · 2026-10-27
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Earnings call transcript: Euronet misses Q3 2026 estimates as stock falls 7%
2026-10-27
Earnings call transcript: Polaris beats Q3 2026 estimates and raises outlook
2026-10-27
Earnings call transcript: Hartford tops Q3 2026 profit forecast, shares slip
2026-10-27
SiteOne earnings loom as volume pressure tests growth story
2026-10-27
Earnings call transcript: Hilton tops Q3 2026 EPS forecast as stock falls 4.3%
2026-10-27
RELATED ON CATALAYER
Related Topics
Treasury Bond Yields & Credit NewsRELATED MARKETS
Prediction Markets